ARCHIVES

Pfizer’s Withdrawal Of Mylotarg Signals Stronger FDA Resolve To Monitor Confirmatory Studies

This article is from The Cancer Letter archive.

Vol. 36 No. 24 | June 25, 2010

Download PDF Visit The Full Archive

Related Articles

Bush Keeps Klausner As NCI Director; Senate Confirms Thompson For HHS.

January 26, 2001

New Treatment For Malignant Glioma, IL13-PE38, Tested In Early Clinical Trials

December 28, 2001

Cooperative group chairman suggest changes to incentive system.

August 13, 2004

Study: Freezing Secondary Tumors Helpful in Metastatic Breast Cancer

March 30, 2012

Heavy Smokers And Drinkers Have Different Brain Chemistry

May 30, 2003

White House Preparing To Nominate Andrew von Eschenbach as FDA Commissioner, Sources Said

March 3, 2006